Tricida, Inc.

2022 Q4 Form 10-Q Financial Statement

#000159558522000087 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $80.22M
YoY Change -45.34%
Cash & Equivalents $17.74M
Short-Term Investments $62.48M
Other Short-Term Assets $2.265M
YoY Change -48.57%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $82.48M
YoY Change -45.44%
LONG-TERM ASSETS
Property, Plant & Equipment $541.0K
YoY Change -35.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $11.40M
YoY Change -15.04%
TOTAL ASSETS
Total Short-Term Assets $82.48M
Total Long-Term Assets $11.40M
Total Assets $93.88M
YoY Change -42.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.395M
YoY Change 34.77%
Accrued Expenses $9.735M
YoY Change -50.72%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $16.93M
YoY Change -34.22%
LONG-TERM LIABILITIES
Long-Term Debt $195.3M
YoY Change
Other Long-Term Liabilities $7.900M
YoY Change
Total Long-Term Liabilities $7.900M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $16.93M
Total Long-Term Liabilities $7.900M
Total Liabilities $230.0M
YoY Change 41.36%
SHAREHOLDERS EQUITY
Retained Earnings -$882.0M
YoY Change 15.99%
Common Stock $56.00K
YoY Change 12.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$136.1M
YoY Change
Total Liabilities & Shareholders Equity $93.88M
YoY Change -42.96%

Cashflow Statement

Concept 2022 Q4 2022 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001595585
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38558
dei Entity Registrant Name
EntityRegistrantName
TRICIDA, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-3372526
dei Entity Address Address Line1
EntityAddressAddressLine1
7000 Shoreline Court
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 201
dei Entity Address City Or Town
EntityAddressCityOrTown
South San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94080
dei City Area Code
CityAreaCode
415
dei Local Phone Number
LocalPhoneNumber
429-7800
dei Security12b Title
Security12bTitle
Common stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
TCDA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
58028254 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17744000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21113000 usd
CY2022Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
62475000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
119419000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2265000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5004000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
82484000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
145536000 usd
CY2022Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
0 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
10043000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
541000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
769000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10854000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12158000 usd
CY2022Q3 us-gaap Assets
Assets
93879000 usd
CY2021Q4 us-gaap Assets
Assets
168506000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4395000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10023000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2797000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2736000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9735000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16721000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
16927000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
29480000 usd
CY2022Q3 us-gaap Convertible Debt
ConvertibleDebt
195347000 usd
CY2021Q4 us-gaap Convertible Debt
ConvertibleDebt
127512000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9851000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11296000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7852000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 usd
CY2022Q3 us-gaap Liabilities
Liabilities
229977000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
168288000 usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
40000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
40000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55694651 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55694651 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55363461 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55363461 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
56000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
55000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
746234000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
810618000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-428000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-91000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-881960000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-810364000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-136098000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
218000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
93879000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
168506000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19935000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26635000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55298000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
78591000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4125000 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9052000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
23119000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
28497000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
24060000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
35687000 usd
us-gaap Operating Expenses
OperatingExpenses
78417000 usd
us-gaap Operating Expenses
OperatingExpenses
107088000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-24060000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-35687000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-78417000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-107088000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
277000 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
408000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
155000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
1978000 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
3994000 usd
us-gaap Interest Expense
InterestExpense
5927000 usd
us-gaap Interest Expense
InterestExpense
13533000 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-6124000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-25761000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-39675000 usd
us-gaap Net Income Loss
NetIncomeLoss
-83936000 usd
us-gaap Net Income Loss
NetIncomeLoss
-126590000 usd
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
47000 usd
CY2021Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-15000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-337000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-141000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25714000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-39690000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-84273000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-126731000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.79
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.79
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.52
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58015939 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58015939 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50434879 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50434879 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57854606 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57854606 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50326474 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50326474 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
218000 usd
CY2022Q1 tcda Stock Issued During The Period Value Share Based Payment Arrangement And Employee Stock Purchase Plan
StockIssuedDuringThePeriodValueShareBasedPaymentArrangementAndEmployeeStockPurchasePlan
41000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6524000 usd
CY2022Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-286000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-29639000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-90300000 usd
CY2022Q2 tcda Stock Issued During The Period Value Share Based Payment Arrangement And Employee Stock Purchase Plan
StockIssuedDuringThePeriodValueShareBasedPaymentArrangementAndEmployeeStockPurchasePlan
639000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7071000 usd
CY2022Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-98000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-28536000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-111224000 usd
CY2022Q3 tcda Stock Issued During The Period Value Share Based Payment Arrangement And Employee Stock Purchase Plan
StockIssuedDuringThePeriodValueShareBasedPaymentArrangementAndEmployeeStockPurchasePlan
53000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6649000 usd
CY2021Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-15000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
787000 usd
CY2022Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
47000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-25761000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-136098000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
108871000 usd
CY2021Q1 tcda Stock Issued During The Period Value Share Based Payment Arrangement And Employee Stock Purchase Plan
StockIssuedDuringThePeriodValueShareBasedPaymentArrangementAndEmployeeStockPurchasePlan
115000 usd
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6042000 usd
CY2021Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-105000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-53362000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
61561000 usd
CY2021Q2 tcda Stock Issued During The Period Value Share Based Payment Arrangement And Employee Stock Purchase Plan
StockIssuedDuringThePeriodValueShareBasedPaymentArrangementAndEmployeeStockPurchasePlan
333000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6609000 usd
CY2021Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-21000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-33553000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
34929000 usd
CY2021Q3 tcda Stock Issued During The Period Value Share Based Payment Arrangement And Employee Stock Purchase Plan
StockIssuedDuringThePeriodValueShareBasedPaymentArrangementAndEmployeeStockPurchasePlan
14000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-39675000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1902000 usd
us-gaap Net Income Loss
NetIncomeLoss
-83936000 usd
us-gaap Net Income Loss
NetIncomeLoss
-126590000 usd
us-gaap Depreciation
Depreciation
231000 usd
us-gaap Depreciation
Depreciation
351000 usd
us-gaap Restructuring Costs
RestructuringCosts
-80000 usd
us-gaap Restructuring Costs
RestructuringCosts
574000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
211000 usd
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-440000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
677000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
7047000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-6124000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
14382000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
19300000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-202000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
0 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-29000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2739000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-105000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5628000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-245000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1095000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-8871000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-70731000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-101996000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
75637000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
136345000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
142500000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
200409000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
76000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
66860000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
63988000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
33000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
733000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
462000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
198000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
0 usd
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
38000 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
83285000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
502000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-82861000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3369000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-120869000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21113000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
137857000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17744000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16988000 usd
us-gaap Interest Paid Net
InterestPaidNet
3500000 usd
us-gaap Interest Paid Net
InterestPaidNet
5274000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-882000000 usd
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
50326474 shares
CY2021Q4 us-gaap Convertible Debt
ConvertibleDebt
127512000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
810618000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-810364000 usd
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
500000 usd
CY2022Q3 us-gaap Purchase Obligation
PurchaseObligation
470696000 usd
CY2022Q3 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
10364000 usd
CY2022Q3 us-gaap Purchase Obligation Due In Second And Third Year
PurchaseObligationDueInSecondAndThirdYear
97393000 usd
CY2022Q3 us-gaap Purchase Obligation Due In Fourth And Fifth Year
PurchaseObligationDueInFourthAndFifthYear
96784000 usd
CY2022Q3 us-gaap Purchase Obligation Due After Fifth Year
PurchaseObligationDueAfterFifthYear
266155000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7900000 usd
CY2021Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
50434879 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
55521273 shares
CY2022Q3 tcda Share Based Compensation Arrangementby Share Based Payment Award Stock Optionsand Rs Us Outstanding
ShareBasedCompensationArrangementbyShareBasedPaymentAwardStockOptionsandRSUsOutstanding
13918236 shares
CY2021Q4 tcda Share Based Compensation Arrangementby Share Based Payment Award Stock Optionsand Rs Us Outstanding
ShareBasedCompensationArrangementbyShareBasedPaymentAwardStockOptionsandRSUsOutstanding
10889603 shares
CY2022Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
30968855 shares
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
28531873 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-25761000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-39675000 usd
us-gaap Net Income Loss
NetIncomeLoss
-83936000 usd
us-gaap Net Income Loss
NetIncomeLoss
-126590000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
55682606 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58015939 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58015939 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50434879 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50434879 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57854606 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57854606 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50326474 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50326474 shares
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.79
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.79
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.45
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.52
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.52
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26969148 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17193906 shares

Files In Submission

Name View Source Status
0001595585-22-000087-index-headers.html Edgar Link pending
0001595585-22-000087-index.html Edgar Link pending
0001595585-22-000087.txt Edgar Link pending
0001595585-22-000087-xbrl.zip Edgar Link pending
exhibit311ceo302certificat.htm Edgar Link pending
exhibit312cfo302certificat.htm Edgar Link pending
exhibit321ceoandcfo906cert.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
patheon_amendmentno3toma.htm Edgar Link pending
patheon_amendmentno3toma001.jpg Edgar Link pending
patheon_amendmentno3toma002.jpg Edgar Link pending
patheon_amendmentno3toma003.jpg Edgar Link pending
patheon_amendmentno3toma004.jpg Edgar Link pending
patheon_amendmentno3toma005.jpg Edgar Link pending
patheon_amendmentno3toma006.jpg Edgar Link pending
patheon_amendmentno3toma007.jpg Edgar Link pending
patheon_amendmentno4toma.htm Edgar Link pending
patheon_amendmentno4toma001.jpg Edgar Link pending
patheon_amendmentno4toma002.jpg Edgar Link pending
patheon_amendmentno4toma003.jpg Edgar Link pending
patheon_amendmentno4toma004.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tcda-20220930.htm Edgar Link pending
tcda-20220930.xsd Edgar Link pending
tcda-20220930_g1.jpg Edgar Link pending
tcda-20220930_def.xml Edgar Link unprocessable
tcda-20220930_lab.xml Edgar Link unprocessable
tcda-20220930_pre.xml Edgar Link unprocessable
tcda-20220930_htm.xml Edgar Link completed
tcda-20220930_cal.xml Edgar Link unprocessable